DURHAM, N.C., March 23, 2017 /PRNewswire/ -- KNOW Bio, LLC, a leading innovator in healthcare, today announced that Life Care Medical Device CEO Richard J. Prati has joined the company's board of directors.
"Richard has strong qualities in identifying companies with unique technologies," said Neal Hunter, Chairman of KNOW Bio, LLC. "His business acumen, especially in the areas of health care devices and creating business opportunities, will be a powerful addition to our Board."
Prati has more than 25 years of proven leadership and operational execution with a wide range of emerging and established public and private entities. He has expertise in industries ranging from health care, biotech, medical devices, conglomerates, retail, industrials, information technology and semiconductors.
"I've long admired what Neal and his team at KNOW Bio are doing with nitric oxide to address a host of diseases and ailments," said Prati. "The idea that many of the complications of these diseases, including cystic fibrosis, could someday become a thing of the past is very exciting, which is why I am looking forward to my role with the company."
In addition to his position at Life Care, Prati co-founded medical technology start-up Singular Medical Technologies and serves as Chairman. He also recently served as Vice Chairman of PVG Asset Management, a fund family with nearly $1 billion in assets and is a board member and early-stage investor of the privately-held Centennial Brands company. In 2002, he co-founded American Technology Research, an independent research broker/dealer. He earned his MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester and his B.S in Economics from Vanderbilt University.
About KNOW Bio
KNOW Bio, LLC was created to develop and optimize the company's proprietary and versatile nitric oxide platform. The technology can be delivered as a drug in a variety of doses and release time frames, which makes the therapeutic areas that will likely be impacted by this platform immense.
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: reliance on key personnel; the early stage of our business; risks associated with the drug development process; competition; and other risks described in other Company press releases and presentations. KNOW Bio assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Razor Sharp PR
SOURCE KNOW Bio, LLC